A detailed history of Thrivent Financial For Lutherans transactions in Alkermes Plc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 129,312 shares of ALKS stock, worth $3.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
129,312
Previous 140,478 7.95%
Holding current value
$3.98 Million
Previous $3.39 Million 6.88%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$23.01 - $28.55 $256,929 - $318,789
-11,166 Reduced 7.95%
129,312 $3.62 Million
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $1.63 Million - $1.92 Million
-70,398 Reduced 33.38%
140,478 $3.39 Million
Q1 2024

May 14, 2024

SELL
$26.4 - $32.56 $3.87 Million - $4.77 Million
-146,426 Reduced 40.98%
210,876 $5.71 Million
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $2.55 Million - $3.13 Million
109,041 Added 43.92%
357,302 $9.91 Million
Q3 2023

Nov 14, 2023

SELL
$27.17 - $31.97 $2.86 Million - $3.36 Million
-105,171 Reduced 29.76%
248,261 $6.95 Million
Q2 2023

Aug 14, 2023

BUY
$28.34 - $33.63 $2.95 Million - $3.51 Million
104,235 Added 41.83%
353,432 $11.1 Million
Q4 2022

Feb 08, 2023

SELL
$21.94 - $26.24 $2.41 Million - $2.88 Million
-109,768 Reduced 30.58%
249,197 $6.51 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $7.9 Million - $11.4 Million
358,965 New
358,965 $8.02 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $643,948 - $924,708
-41,842 Closed
0 $0
Q3 2020

Nov 10, 2020

SELL
$16.16 - $20.66 $887,571 - $1.13 Million
-54,924 Reduced 56.76%
41,842 $694,000
Q1 2020

May 15, 2020

BUY
$13.06 - $21.24 $585,296 - $951,891
44,816 Added 86.27%
96,766 $1.4 Million
Q4 2019

Feb 13, 2020

BUY
$17.29 - $21.74 $898,215 - $1.13 Million
51,950 New
51,950 $1.06 Million
Q4 2018

Feb 15, 2019

SELL
$27.94 - $44.61 $191,919 - $306,426
-6,869 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$38.6 - $46.12 $265,143 - $316,798
6,869 New
6,869 $292,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.05B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.